World's Best Scientists 2026 revealed!
Boadie W. Dunlop

Boadie W. Dunlop

D-Index & Metrics

Psychology

D-Index
54
Citations
13476
World Ranking
4538
National Ranking
2521

Boadie W. Dunlop publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Boadie W. Dunlop sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 239 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Boadie W. Dunlop D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Boadie W. Dunlop sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 54 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Boadie W. Dunlop is affiliated with Emory University in the United States. Their research spans the fields of Medicine, Neuroscience, and Psychology, with a significant focus on Pharmacology, Clinical Psychology, Biological Psychiatry, Cognitive Neuroscience, and Experimental and Cognitive Psychology.

The scientist's work primarily addresses topics including tryptophan and brain disorders, treatment of major depression, psychedelics and drug studies, functional brain connectivity studies, mental health research topics, stress responses and cortisol, and chemical synthesis and alkaloids.

Recent notable papers authored or co-authored by Boadie W. Dunlop include:

  • "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression" (2022), published in New England Journal of Medicine
  • "Single-Dose Psilocybin Treatment for Major Depressive Disorder" (2023), published in JAMA
  • "Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life" (2023), published in Journal of Affective Disorders
  • "Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression" (2021), published in Translational Psychiatry
  • "Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature" (2021), published in Scientific Reports

The frequent co-authors collaborating with Boadie W. Dunlop are:

  • Helen S. Mayberg
  • W. Edward Craighead
  • Rima Kaddurah-Daouk
  • Ki Sueng Choi
  • A. John Rush

Boadie W. Dunlop has published extensively in venues such as Biological Psychiatry, bioRxiv (Cold Spring Harbor Laboratory), Journal of Affective Disorders, Molecular Psychiatry, and Psychiatry Research.

Best Publications

  • The role of dopamine in the pathophysiology of depression.

    Boadie W. Dunlop;Charles B. Nemeroff

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

    Unknown

  • Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder

    Callie L. McGrath;Mary E. Kelley;Paul E. Holtzheimer;Boadie W. Dunlop

  • A Randomized, Double-Blind Evaluation of d-Cycloserine or Alprazolam Combined With Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder in Iraq and Afghanistan War Veterans

    Barbara Olasov Rothbaum;Matthew Price;Tanja Jovanovic;Seth D. Norrholm

  • Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.

    Unknown

  • MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity

    Orna Issler;Sharon Haramati;Evan D. Paul;Hiroshi Maeno

  • Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder

    Boadie W. Dunlop;Boadie W. Dunlop;Boadie W. Dunlop;Justin K. Rajendra;Justin K. Rajendra;Justin K. Rajendra;W. Edward Craighead;W. Edward Craighead;W. Edward Craighead;Mary E. Kelley;Mary E. Kelley;Mary E. Kelley

  • Psychosocial treatments for major depressive disorder.

    W. Edward Craighead;Benjamin N. Johnson;Sean Carey;Boadie W. Dunlop

  • Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.

    John F. Greden;Sagar V. Parikh;Anthony J. Rothschild;Michael E. Thase

  • D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.

    David Mataix-Cols;Lorena Fernández de la Cruz;Benedetta Monzani;David Rosenfield

  • The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions.

    Boadie W. Dunlop;Andrea Wong

  • Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.

    Erica S. Weitz;Steven D. Hollon;Jos Twisk;Annemieke van Straten

  • Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response

    Shariful A. Syed;Eleonore Beurel;David A. Loewenstein;Jeffrey A. Lowell

  • Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.

    Chad A Bousman;Chad A Bousman;Katarina Arandjelovic;Serafino G Mancuso;Harris A Eyre

  • Pretreatment Brain States Identify Likely Nonresponse to Standard Treatments for Depression

    Callie L. McGrath;Mary E. Kelley;Boadie W. Dunlop;Paul E. Holtzheimer;Paul E. Holtzheimer

  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

    Unknown

  • Neuroimaging-based biomarkers for treatment selection in major depressive disorder.

    Boadie W Dunlop;Helen S Mayberg

  • Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial.

    Boadie W. Dunlop;Elisabeth B. Binder;Elisabeth B. Binder;Joseph F. Cubells;Mark M. Goodman

  • Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.

    Pim Cuijpers;Erica Weitz;Jos Twisk;Christine Kuehner

  • Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study

    Boadie W. Dunlop;Mary E. Kelley;Vivianne Aponte-Rivera;Tanja Mletzko-Crowe

  • BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity

    Jeffrey Rakofsky;Kerry Ressler;Boadie W Dunlop

  • Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review

    Boadie W. Dunlop;Paula G. Davis

  • Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder.

    Boadie W. Dunlop;Mary E. Kelley;Tanja C. Mletzko;Cristina M. Velasquez

  • The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder

    Steven J. Garlow;Boadie W. Dunlop;Philip T. Ninan;Charles B. Nemeroff

Frequent Co-Authors

Helen S. Mayberg
Helen S. Mayberg Icahn School of Medicine at Mount Sinai
W. Edward Craighead
W. Edward Craighead Emory University
Charles B. Nemeroff
Charles B. Nemeroff The University of Texas at Austin
Elisabeth B. Binder
Elisabeth B. Binder Max Planck Society
Michael E. Thase
Michael E. Thase University of Pennsylvania
Richard C. Shelton
Richard C. Shelton University of Alabama at Birmingham
Barbara O. Rothbaum
Barbara O. Rothbaum Emory University
Sanjay J. Mathew
Sanjay J. Mathew Baylor College of Medicine
Sagar V. Parikh
Sagar V. Parikh University of Michigan–Ann Arbor
Dan V. Iosifescu
Dan V. Iosifescu New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology opens up a range of online programs and flexible learning options. Many students choose to specialize in mental health counseling due to growing demand across the U.S. While an online psychology degree can provide strong foundational knowledge, becoming a licensed counselor typically requires additional education and supervised experience.

Requirements for becoming a mental health counselor vary depending on location. For example, you can explore Milwaukee mental health counselor education requirements to understand the specific steps needed in that city. Similarly, researching how to become a mental health counselor in Minneapolis offers valuable insights for those interested in Minnesota.

If your career plans take you to the South, you may find it helpful to review Nashville mental health counselor certification requirements or learn more about mental health counselor requirements in New Orleans. Each region has its own licensing boards and unique expectations for education, internship hours, and examination.

As you consider your career pathway, be sure to review your intended state’s requirements early to plan your academic journey effectively.

Best Scientists Citing Boadie W. Dunlop

Trending Scientists